OxySure Systems, Inc. (OXYS) Kept with Buy Rating at Sterling Investment Services, PT Set at $1.90

Analysts at Sterling Investment Services today reiterated the Buy rating on medical technology company OxySure Systems. The firm set a 12-month price target of $1.90 on OXYS’ common stock.

This is the third recently issued Buy rating on OXYS with a price target in the range of $1.75 to $2.10.

OxySure focuses on the design, manufacture, and distribution of specialty respiratory and medical solutions. The company pioneered an FDA-approved solution to produce medically pure (USP) oxygen from inert powders for emergency and short duration use. The company owns several issued patents and patents pending on this technology, which makes the provision of emergency oxygen safer, more accessible, and easier to use than traditional oxygen provision systems.

To see the Sterling report in its entirety, visit http://oxysure.com/aed/sterlingoxysure.pdf. For more information on OxySure, visit www.OxySure.com.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

 The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net